The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
UNITY BIOTECHNOLOGY INC Common 91381U200   239,476 124,081 SH   SOLE   124,081 0 0
Zentalis Pharmaceuticals Inc Common 98943L107   2,835,216 187,143 SH   SOLE   187,143 0 0
Neuroone Medical Technologies Common 64130M209   287,171 181,754 SH   SOLE   181,754 0 0
ImmunityBio Inc Com Common 45256X103   7,043 1,403 SH   SOLE   1,403 0 0
Immunome Inc Com Common 45257U108   1,160,736 108,480 SH   SOLE   108,480 0 0
Scilex Holding Co Common 80880W106   86,298 42,303 SH   SOLE   42,303 0 0
MSCI ACWI ETF Common 464288257   11,575,014 113,737 SH   SOLE   113,737 0 0